Molecular Carcinogenesis Group International Agency for Research on Cancer Lyon, France
hainaut@iarc.fr
Tumor-specific, 'signature' mutations of p53 have been identified in several cancers. The molecular basis of these tissue-specific selections has been poorly understood. A recent report sheds light on this issue by identifying the molecular basis of one such signature mutation found in adrenal cortical carcinomas.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS TOUCHINGbase Nature Genetics News and Views (Touching Base) (01 Feb 2002)
